Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Robin

Showing results (141-150 of 298) with videos related to

Pageof 30
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantationNicolas Dulphy, Philippe Haas, Marc Busson, et al.
Blood|December 6, 2014
Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumabRégis Peffault de Latour, Véronique Fremeaux-Bacchi, Raphaël Porcher, et al.
Haematologica|July 6, 2014
Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMTYves Chalandon, Jakob R Passweg, Cesare Guglielmi, et al.
Haematologica|October 26, 2010
Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosisNicolaus Kröger, Tatjana Zabelina, Anja van Biezen, et al.
Bulletin Du Cancer|December 18, 2021
[DESCAR-T, a nationwide registry for patient treated by CAR-T Cells in France]Florence Broussais, Jacques Olivier Bay, Nicolas Boissel, et al.
Haematologica|January 2, 2015
Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow TransplantationChristian Koenecke, Gudrun Göhring, Liesbeth C de Wreede, et al.
British Journal of Haematology|April 4, 2018
Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA studyBenedicte Deau, Sandy Amorim, Aurore Perrot, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2025
Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosisSara Villar, Emmanuel Curis, Marie-Hélène Schlageter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 18, 2019
Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell TransplantationSimona Pagliuca, Côme Bommier, David Michonneau, et al.
European Journal of Haematology|May 2, 2018
Alemtuzumab vs anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioningMarie Robin, Kavita Raj, Sylvie Chevret, et al.
Pageof 30

Showing results (141-150 of 298) with videos related to

Sort By:
Pageof 30
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2008
An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantationNicolas Dulphy, Philippe Haas, Marc Busson, et al.
Blood|December 6, 2014
Assessing complement blockade in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumabRégis Peffault de Latour, Véronique Fremeaux-Bacchi, Raphaël Porcher, et al.
Haematologica|July 6, 2014
Early administration of donor lymphocyte infusions upon molecular relapse after allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia: a study by the Chronic Malignancies Working Party of the EBMTYves Chalandon, Jakob R Passweg, Cesare Guglielmi, et al.
Haematologica|October 26, 2010
Allogeneic stem cell transplantation for myelodysplastic syndromes with bone marrow fibrosisNicolaus Kröger, Tatjana Zabelina, Anja van Biezen, et al.
Bulletin Du Cancer|December 18, 2021
[DESCAR-T, a nationwide registry for patient treated by CAR-T Cells in France]Florence Broussais, Jacques Olivier Bay, Nicolas Boissel, et al.
Haematologica|January 2, 2015
Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow TransplantationChristian Koenecke, Gudrun Göhring, Liesbeth C de Wreede, et al.
British Journal of Haematology|April 4, 2018
Tandem haematopoietic stem cell transplantation for High Risk relapsed/refractory Hodgkin Lymphoma: a LYSA studyBenedicte Deau, Sandy Amorim, Aurore Perrot, et al.
Cancer Immunology, Immunotherapy : CII|April 24, 2025
Ruxolitinib stopped before transplantation does not induce cytokine release in myelofibrosisSara Villar, Emmanuel Curis, Marie-Hélène Schlageter, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 18, 2019
Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell TransplantationSimona Pagliuca, Côme Bommier, David Michonneau, et al.
European Journal of Haematology|May 2, 2018
Alemtuzumab vs anti-thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioningMarie Robin, Kavita Raj, Sylvie Chevret, et al.
Pageof 30